Fasting vs. keto vs. both: which diet boosts metabolic health best?
NCT ID NCT07659093
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares three dietary approaches—intermittent fasting (16:8 schedule), a clean ketogenic diet (20g carbs per day from whole foods), and a combination of both—in healthy adults. Researchers measure changes in body composition, cholesterol, triglycerides, and blood sugar control. The goal is to see which strategy most improves cardiometabolic markers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dietary intervention (clean ketogenic diet and/or intermittent fasting)
- What this could lead to
- If successful, this could help identify which dietary approach best improves cholesterol, blood sugar, and body composition for metabolic health.
- What could go wrong
- This is a small, non-randomized analysis of two sequential studies, so results may not apply broadly. Dietary adherence can vary, and long-term effects are not assessed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Tennessee at Martin
Martin, Tennessee, 38238, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test